Soleno Therapeutics (SLNO) Other Non Operating Income (2013 - 2023)

Soleno Therapeutics (SLNO) has 11 years of Other Non Operating Income data on file, last reported at $2.1 million in Q4 2023.

• Other Non Operating Income for Q4 2023 came in at $2.1 million, up 1615.2% year-over-year; the trailing twelve-month figure through Dec 2023 was $2.6 million (up 759.33% YoY), and the FY2023 annual result was $2.6 million, up 759.33% from the prior year.
• Other Non Operating Income improved to $2.1 million in Q4 2023 per SLNO's latest filing, from $174000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $2.1 million in Q4 2023 and troughed at $1000.0 in Q2 2020.
• A 5-year average of $166052.6 and a median of $41000.0 in 2021 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2020 and 2021: Other Non Operating Income plunged 97.87% in 2020, then jumped 4000.0% in 2021.
• A 5-year view of Other Non Operating Income shows it stood at $21000.0 in 2019, then sank by 95.24% to $1000.0 in 2020, then surged by 3300.0% to $34000.0 in 2021, then surged by 267.65% to $125000.0 in 2022, then jumped by 1615.2% to $2.1 million in 2023.
• Business Quant data shows SLNO's Other Non Operating Income at $2.1 million in Q4 2023, $174000.0 in Q3 2023, and $147000.0 in Q2 2023.